1. The fractional clearance of intact albumin as determined by fractionation of urine by gel chromatography gave a value of 3.9k1.6 x for the isolated perfused kidney and 2.1 k0.6 x in vivo using ALZET osmotic pumps. 2. Albumin fractional clearance as measured by detection of the tritium label on the albumin molecule by radioactivity analysis gave a value of 7.5k 3.9 x for the isolated perfused kidney and 2.3 3. The major differences between assays that detect intact albumin compared with non-specific assays in the estimates of the fractional clearance of albumin can be explained by the degradation of approx. 90% of albumin to small peptides during its renal passage. This has been demonstrated by size exclusion chromatography of urine samples from experiments where (i) exogenous tritium-labelled albumin was used in isolated perfused kidneys, (ii) exogenous tritium-labelled albumin was administered intravenously and (iii) analysis was made with metabolically labelled endogenous albumin in vivo.
INTRODUCTION
The apparent marked restriction of albumin transport across the glomerular capillary wall compared with other proteins or dextrans of similar size is unique. Transport studies in both continuous and fenestrated capillaries in the body demonstrate that albumin transport is not excessively restricted in relation to other proteins or dextrans [l] . For example, the peritubular capillary sieving coefficient for albumin is 0.33 as calculated from the lymph/ plasma ratio [2] , while the sieving coefficient of albumin has been found to be 0.51 to 0.74 in the gastrointestinal tract [2] and 0.23 to 0.38 in subcutaneous tissue [2] . In all these capillary beds the restriction to dextran of equivalent hydrodynamic radius to albumin is similar to that observed across the glomerular capillary wall [l] .
The relatively high sieving coefficient values for albumin in non-glomerular capillary beds are supported by other studies where the glomerular fractional clearance of albumin was measured as 0.02 to 0.06 by glomerular volumetric analysis in isolated rat glomeruli [3, 41. Furthermore, the relative difference in permeability between albumin and dextran across isolated glomerular basement membrane systems does not reflect the differences seen in vivo [5 ,6] , as sieving coefficients across isolated basement membranes have been found to be between 0.05 and 0.1 It appears that one of the major difficulties in elucidating the mechanism of the renal processing of albumin has been the marked variation in the published values of its glomerular sieving coefficient (GSC) and urinary fractional clearance (combination of GSC and tubular reabsorption). The GSC for albumin has been obtained mainly from micropuncture experiments which sample the post-glomerular early proximal tubular space. It has been assumed that the ratio of plasma concentration to early proximal tubular lumen concentration equates with the GSC. Micropuncture studies have estimated the concentration of filtered albumin in proximal tubules to be in the range of 0.1 to 50mg/100ml for normal kidneys [9-221 and 3 .0 to 650 mg/100 ml for diseased kidneys [13] [14] [15] [16] [17] [18] 211 . Initial micropuncture studies determined the GSC of albumin to be between 1.0 x when protein in the early proximal fluid was measured by non-specific total protein assays. More recent measurements of GSC, using specific radioimmunoassay or disc electrophoresis for albumin analysis, have yielded lower values of 2 3.0 x [19] [20] [21] [22] . These values represent a partitioning of albumin (i.e. the concentration ratio of albumin in the Bowman's space as compared with plasma) at the glomerular capillary wall of > 1 : 3000.
The micropuncture studies give GSCs of albumin which in some cases are quantitatively lower than those obtained through urinary fractional clearance studies on kidneys. Measurements in vivo of the GSC of albumin in rats from fractional clearance studies have varied from 6.0 x by Bertolatus and Hunsicker [23] to 3.0 x by Bertolatus et al. [24] , where allowance was made for tubular reabsorption by assuming that albumin accumulated in the tubules of the whole kidney as measured by trichloroacetic acid (TCA)-insoluble radiolabelled albumin. Purtell et al. [25] , who did not correct for tubular reabsorption, found a fractional clearance (equivalent to the GSC) of 5.0-7.0 x lop3. The fractional clearance of albumin as measured by Lowry assay was 1 . 0~1 0 -~ for studies in vivo in rat [19] and 7.6-72.0 x in the isolated perfused kidney (IPK) [19, 261. This compares with micropuncture studies which gave a GSC of 2.7 x in vivo and 2.3 x in the IPK [19] ; in both cases the albumin concentration was estimated by ultra-microdisc electrophoresis with Coomassie Blue stain.
Rationalization of some of this variation, particularly for the fractional clearance studies, can be made with the recognition that albumin which appears in the urine is significantly degraded [27, 281 and that the degraded protein may not be detected by specific albumin assays or included in TCA precipitates. The degradation which has now been shown to occur for a number of proteins [28] may considerably influence clearances, particularly for assays designed for the specific analysis of intact albumin or other intact protein. Under such circumstances the assay may vastly underestimate the total renal clearance of the protein.
The above range of values for the clearance of albumin is still too large to permit conclusions to be drawn about the degree of glomerular sieving and the renal turnover rate of albumin. Thus, the aim of this study was to compare various techniques to measure urinary albumin concentration. We examine the fractional clearance of albumin by the fractionation of urine samples, obtained from both studies in the IPK and in vivo using ALZET osmotic pumps, by size exclusion chromatography using tritium-labelled albumin. The fractional clearance of albumin was also determined using various nonspecific protein assays. The processing of exogenous labelled albumin was then compared with that of endogenous labelled albumin.
METHODS

Materials
Male Sprague-Dawley rats (300-350 g) were obtained from the Monash University Central Animal House. Catalase (EC 1.11.1.6) (1600 i.u./mg solid from bovine liver), sulphosalicylic acid, thimerosal, sodium azide, benzoylated dialysis tubing (molecular mass cut-off of 2000 Da) and the amino acids lysine, tyrosine, serine, cysteine, aspartate, glutamate, asparagine and glutamine were obtained from Sigma Chemical Co. (St. Louis, MO, U.S.A.). BSA (Fraction V, fatty acid free) and superoxide dismutase (EC 1.15.1.1) (5000 i.u./mg solid from bovine erythrocytes) were purchased from Boehringer Mannheim GmbH Biochemica (Mannheim, Germany). Sephadex G-100, Sephadex G-25 in PD-10 columns and blue dextran T2000 were purchased from Pharmacia Fine Chemicals (Uppsala, Sweden). Nembutal (60 mg/ml) was from Cera Chemicals Australia Pty Ltd (Hornsby, NSW, Australia). Synthamin (a source of amino acids) was from Travenol Laboratories (NSW, Australia 
Solutions and buffers
PBS, pH 7.4, contained 136.9 mmol/l NaCl, 2.68 mmol/l KCl, 8.1 mmol/l NazHP04 and 1.5 mmol/l KHzP04. Krebs-Henseleit buffer, pH 7.4, contained 122 mmol/l NaCl, 4.6 mmol/l KCl, 0.115 mmol/l KHzPO4, 0.115 mmol/l MgS04, 24.9 mmolfl NaHC03 and 0.1 mmol/l CaClz.Hz0. Sodium phosphate buffer (0.067 mol/l, pH 6.2) contained 18.5 ml of 0.067 mol/l NazHP04 and 81.5 ml of 0.067 mol/l NaHzP04.2H20. Kidney perfusate solution was 5% BSA in Krebs-Henseleit buffer that contained 5 mmol/l glucose and 36 mg of mannitol, 10 600 i.u. of superoxide dismutase and 110 000 i. 
Tritium labelling
BSA was labelled with tritium by the reductive methylation procedure of Tack et al. [29] . This reaction involves a brief exposure to formaldehyde and sodium b~ro[~H]-hydride. The tritium labelling is specific for the cc-amino groups of the amino terminal residues and the &-amino groups of lysyl residues. The labelled preparation was applied to a Sephadex G-25 PD-10 column to separate it from free label. The purity of the [3H]BSA preparation was ensured by extensive dialysis of the sample (approx. lo9 d.p.m./ml; 3.5 ml) using dialysis tubing with a molecular mass cut-off of 2000Da until no tritium was found in the dialysate (volume = 4 1). Assuming that there is less than 100 d.p.m./ml in the dialysate, this indicates that less than 0.0025% of the original sample could be contaminated with free tritium or low-molecular-mass-labelled material. The dialysed preparation was again applied to a PD-10 column immediately before use. The activity of [3H]BSA was 2.31 x lo8 d.p.m./mg.
Kidney petfusion
Male Sprague-Dawley rats were anaesthetized by a 1 ml intraperitoneal injection of 18 mg/ml pentobarbitone (Nembutal). (Male rats were used as the cannulation of the renal artery is simpler due to the proximity of the mesenteric artery.) PBS (1 ml) containing 10% mannitol and 200 i.u. of sodium heparin was injected into the femoral vein. A laparotomy was performed and the right ureter cannulated with polyethylene tubing (PE-10; Dural Plastics and Engineering, Auburn, NSW, Australia). The right renal artery was cannulated via the superior mesenteric artery and the kidney was removed by en bloc dissection. This whole procedure took no longer than 10 min. The perfusion pressure was maintained at 90-100 mmHg with a peristaltic pump monitored by a calibrated aneroid manometer, while kidneys had an average flow rate of approximately 25 ml/min as monitored by a ball flowmeter. Kidneys were perfused with 160 ml of recirculated filtered 5% BSA in Krebs-Henseleit buffer containing glucose, essential amino acids [30-321 and oxygen radical scavengers to prevent partial ischaemia [32] . The system was maintained at 37°C and the perfusate was continually gassed with 95% 02-5% C02. The kidney was allowed to equilibrate for 10 min and urine and perfusate samples collected after 40 and 60 min of perfusion. The perfusate contained approx. 1 x lo6 d.p.m./ml [3H]BSA. Measurement of glomerular filtration rate (GFR) was made with [carboxyl-14C]inulin. Determination of fractional clearance was made by Lowry assay [33] (controls for the Lowry assay were performed by subtracting the chromogen in the supernatant after TCA precipitation of the urine sample), Biuret assay [34], sulphosalicylic acid turbidity method [35] , radioimmunoassay (all using BSA as standard) or radioactive counting for tritium-labelled protein.
To determine the fractional clearance by the specific analysis of intact albumin in urine and perfusate, samples were analysed on a Sephadex G-100 column (1.6 x 60 cm2) eluted with PBS at 20 ml/h at 4°C. One-millilitre samples were loaded and 95 fractions of 1.65 ml each were collected. These samples were then analysed for radioactivity. The void volume (V,) was determined with blue dextran T2000 and the total volume (K) with tritiated water. (wt/vol.) to inhibit bacterial growth. The pump was incubated in PBS containing 0.02% sodium azide at 37°C for 4 h before implantation. The pump was wiped with 70% isopropanol and implanted subcutaneously on the back of an anaesthetized male Sprague-Dawley rat, slightly posterior to the scapulae, using sterile technique. Rats were maintained in a metabolic cage with free access to food and water. Urine was collected for 24 h periods with a corresponding blood sample from the tail vein. Urine and blood samples were centrifuged at 3500rpm in a KUBOTA bench top centrifuge for 10 min and then analysed for radioactivity. GFR was estimated by creatinine assay.
A separate group of male Sprague-Dawley rats were also injected with 1 x los d.p.m./ml [3H]BSA in O.8ml PBS in the tail vein and maintained in a metabolic cage with free access to food and water. Urine samples were collected after 2 h and were analysed on a Sephadex G-100 column as described above.
Synthesis of endogenous [3H]albumin in vivo and its appearance in urine
Male Sprague-Dawley rats were injected with 0.3 ml (300 pCi) of [3H]lysine via the tail vein and then maintained in a metabolic cage with free access to food and water. Urine was collected after 1 h; the rats were then killed and blood was collected by cardiac puncture. Ten millilitres of blood were collected into a syringe containing 1 ml of 3.8% sodium citrate. This suspension was centrifuged at 3000 rpm for 30 min and the serum was removed. Samples of urine and serum were analysed on a Sephadex G-100 column as described above.
Radioimmunoassay
The 12sI-BSA was prepared by the Chloramine T method [38] . One-hundred microlitres of sample, 100 pl of the first antibody, rabbit anti-cow albumin, 100 p1 of [12sI]BSA and 30Opl of PBS containing 0.4% gelatine were added to each tube. After vortexing, the tubes were incubated at room temperature for 4 h. One-hundred microlitres of the second antiserum, sheep anti-rabbit, was then added to each tube which were again vortexed and incubated overnight at room temperature. Polyethylene glycol (750~1, 8%) was added to tubes which were then vortexed and centrifuged at 3500rpm for 30min at 4°C. Supernatants were decanted and precipitates estimated for radioactivity. The standard curve was prepared by diluting a solution (1 mg/ml) of BSA in PBS to give a range of 4000 to 31.2 ng/ml.
Counting of radioactivity
3H and 14C radioactivity were determined in 1 ml aqueous samples with 3 ml of scintillant [39] and recorded on a Wallac 1410 liquid scintillation counter (Wallac Oy, Turku, Finland). 1251 radioactivity was recorded by a Packard crystal 5412 gamma counter.
Calculations
where n represents the number of determinations.
All quantitative data are expressed as means k SD
RESULTS
Fractional albumin clearance in the isolated perfused rat kidney
The IPK preparation, when studied over a 1 h period, has been shown by this laboratory to be a steady-state, stable preparation over this time period [27] with an average GFR and urine flow rate (UFR) of 0.828 k0.166 ml/min and 0.148 k0.065 ml/min (n = 6), respectively. BSA is the only filterable protein in the perfusate used in IPK experiments. The other proteins added to the perfusate, namely catalase and superoxide dismutase at concentrations of 0.196 mg/ml and 5.5 x mg/ml respectively, are too low in concentration and too high in molecular mass to be filtered in detectable quantities.
The gel chromatographic profile on Sephadex G-100 of [3H]BSA from a 60min perfusate sample ( only from the original material that has a profile similar to that shown in Fig. la) has been used in vivo and in the IPK [28] . When the fractional clearance of [3H]BSA was determined by the specific analysis of intact albumin from the area under the bell-shaped curve of the chromatographic profiles (centred at fraction 41 in Figs l a to lc), a value of 3.9 rfi 1.6 x (n = 6) was obtained. When the fractions eluted from the Sephadex G-100 column were assayed for BSA by radioimmunoassay (Fig. 2) and absorption at 280nm, only the intact BSA peak was detected by radioimmunoassay with no evidence of any low-molecu- lar-mass material in spite of its presence as detected by absorption at 280nm. This suggests that the radioimmunoassay is specific for intact albumin and does not detect small BSA fragments. When urine is precipitated, as in the sulphosalicylic acid turbidity assay, only intact albumin and its large fragments would be detected. This resulted in a measured fractional clearance from IPK experiments of 9.2f2.4 x (n = 6) which is higher than that obtained for intact albumin as determined by gel chromatography in the IPK. It is of interest to note that the TCA-precipitable fraction in urine from IPKS can only recover 56.0+ 16.6% (n = 5) of the radioactivity due to the [3H]BSA molecule [27] .
The fractional clearance of [3H]BSA as measured by total radioactivity in the urine was 7.5 k 3.9 x whereas the fractional clearance as measured by Biuret assay (detects peptide bonds) of urine samples was 6.0k3.3 x The Lowry assay gave a value of 1.8 0.7 x (n = 6 for all assays). The good agreement between the fractional clearance determined by radioactivity and that determined by the Biuret assay provides strong support that the two types of measurements are essentially measuring the clearance of material derived from albumin alone. It also demonstrates that the Lowry assay underestimates fractional clearance, most probably due to the influence on this assay of contaminants/ conditions of urine samples as noted also by Tojo and Endou [22] .
Fractional clearance in vivo
The fractional clearance of rH]BSA in vivo was determined by using implanted ALZET osmotic pumps which release a slow, continuous infusion of tracer. Figure 3 shows a time course of plasma levels of rH]BSA which tended to increase slowly until they plateaued at day 5. Hence fractional clearances were calculated after this time at day 6. The GFR was determined by creatinine assay and was found to be 1.4420.39 ml/min (n = 4) and the UFR was 5.9 k 1.7 x ml/min (n = 4). The fractional clearance of total [3H]BSA was found to be 2.3 k0.9 x (n = 4) for intact [3H]BSA as shown in Table 1 . Since the d.p.m. present in urine fractions collected from the osmotic pump experiments was too low to be analysed by size exclusion chromatography, the fractional clearance for intact [3H]BSA was calculated by assuming that the degradation profile of urinary [3H]BSA in osmotic pump experiments was similar to that obtained from injecting [3H]BSA intravenously.
It is of interest to note that the differences in the chemical assay results for IPK urine described above are also reflected in the total protein fractional clearances measured in viva Measurements of the fractional clearance of albumin in vivo with the Biuret assay gave a value of 1.25 k0.39 x the Lowry assay gave 0.70k0.16 x whereas the sulphosalicylic acid turbidity assay gave 0.13 k0.03 x (this assumes that the plasma protein concentration in the rat is 70 mg/ml) (n = 10 for all assays).
(n = 4) and 2.1 k0.6 x Table 1 . Fractional clearance of albumin in vivo (n = 4). 
Synthesis and excretion of endogenous [3H]lysinelabelled albumin in vivo
The evidence that is presented in this paper and elsewhere [27, 281 supports the concept that the normal turnover of rat albumin is, in part, associated with its excretion in the urine as a mixture of intact and degraded peptides. In an effort to demonstrate this in vivo, we injected [3H]lysine intravenously in order to synthesize labelled albumin and examine its possible urinary excretion. Figure 4 shows the gel chromatographic profiles of labelled material in both plasma and urine collected 1 h post-injection. The plasma profile demonstrates that within 1 h albumin is synthesized and is detectable by column chromatography. The peak eluting at fraction 35 was identified as albumin by radioimmunoassay adapted for the detection of rat serum albumin (note that this column has slightly different dimensions to that used in Figs. 1 and 2 ). The peak eluting at the void volume of the column may repre- sent synthesized immunoglobulins whereas the material eluting at the total volume is free lysine. The major feature of the gel chromatographic profile was its marked similarity to the profiles obtained from filtered [3H]BSA in vivo (Fig. lc) and in the IPK (Fig. lb) . In both experiments, a large amount of low-molecular-mass macromolecular material was excreted. In vivo, it is most probably derived from albumin but we cannot eliminate the possibility of a contribution from synthesized low-molecular-mass proteins that exist in plasma.
DISCUSSION
It is commonly stated in the literature that filtered albumin is taken up by the tubules, degraded in the lysosomes and the resulting amino acids are returned to the circulation. Surprisingly, this pathway has never been demonstrated in vivo, particularly in terms of the presence of tubular degradation products in the circulation [40] . Studies in both the IPK and in vivo have demonstrated that albumin is degraded to peptides (not amino acids) that are excreted in the urine. There is no return of albumin degradation products to the circulation [27, 281. These conclusions have been primarily derived from the use of [3H]albumin which has been shown to be processed in the same manner as unlabelled albumin [27, 281. Further evidence for this is shown in Fig. 2 where unlabelled peptides are seen to be excreted in the IPK. Note also that we have failed to identify any extrarenal degradation of albumin leading to degradation products present in the plasma [28] that may be ultimately excreted.
This study demonstrates that the degradation of albumin has a marked effect on the estimation of the fractional renal clearance of albumin. The fractional clearance of total [3H]BSA in the IPK as determined by total radioactivity was found to be 7.5 k3.9 x lop3. This is approximately 20-fold higher than the fractional clearance of intact [3H]BSA of 3.90 & 1.6 x as determined by size exclusion chromatography. This trend is also observed in vivo using osmotic pumps where the fractional clearance of total [3H]BSA was 2.3 k0.9 x lop3, and 2.1 f 0.6 x for intact [3H]BSA. The similarity between the fractional clearance as determined by total radioactivity and the Biuret assay in the IPK demonstrates that the radioactivity is associated with degraded albumin peptides. Albumin appears to be degraded in the tubules and this may be associated with internalization by tubular cells [27, 281. This may ultimately affect the size of the material released and excreted as compared with that retained within the tubular cell. In any case, our results suggest that any unlabelled peptide material derived from the labelled material during perfusion is negligible.
The fractional clearance of [3H]BSA as measured by the specific analysis of intact albumin in the urine of the IPK by gel chromatography (3.90+ 1.6 x is comparable to the fractional clearance of intact albumin in vivo (2.1 10.6 x loM4). Furthermore, it is similar to a previous study by Stolte et al. [19] who used the Lowry assay (which may underestimate clearance [22, 271) to give a value of 1.50 10.14 x This demonstrates that the IPK technique closely mimics the processing of intact albumin in vivo.
While low-molecular-mass proteins are seen in fluid from the early proximal tubule obtained through micropuncture [22] , the amount observed would not account for the ratio of intact to degraded albumin that has been observed in urine collected from both the IPK and in vivo [27, 281. This may be due to the underestimation of albumin in these samples through mixing/convection in the tubule where albumin may be reabsorbed before collection. Degradation may also occur later in the tubule region. Surface glomeruli used for micropuncture may also not represent a true average of all the glomeruli associated with filtration.
In an effort to compare the processing of exogenous with endogenous albumin we examined [3H]albumin synthesized in vivo. The chromatographic profiles of the urine were remarkably similar to those obtained with exogenous [3H]albumin. It is of interest too that previous studies on the turnover of albumin in rats have been unable to account for the differences in albumin synthesis (as measured by a specific electrophoresis assay) of 3.6 mg h-l 100 g-' body wt and catabolism measured as 4.36mg h-l100g-' body wt [41] . Albuminuria was measured for intact albumin and gave a value of 0.022 mg h-' 100 g-l body wt [41] which would translate to 2.32 mg h-' 100 g-' body wt if we used the fractional clearance from radioactivity as measured in vivo (Table l) . We would suggest that part of the difference between albumin synthesis and catabolism could be accounted for by the rapid synthesis and excretion of degraded albumin where the latter would not be detected by specific (intact) albumin assays. This would result in an underestimation of the amount of albumin synthesized.
Finally, it is apparent that measuring intact albumin alone in urine will severely underestimate the albumin associated with glomerular filtration. When the excretion of degraded albumin is taken into account the fractional clearance may increase by 20-fold. This is not enough, however, to explain why albumin has such a highly restricted transport across the glomerular capillary wall when compared with its transport in other capillary beds.
